跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOHONOS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SOHONOS
Authorized
STANDARD
SOHONOS
ipsen biopharmaceuticals canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
87f1a32ae6a3b909
Company
ipsen biopharmaceuticals canada inc
Type
Standard
Approval Details
Approval Id
87f1a32ae6a3b909
Drug Approval Canada Name
SOHONOS
Product Name
SOHONOS
Status
Marketed
Status Date
2022-06-20
Original Market Date
2022-06-20
Din
02524643
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:92.00
Atc Original
M09AX11 PALOVAROTENE
Atc Name
m 09 ax 11
Aig Number
0163378003
Company Name
ipsen biopharmaceuticals canada inc
Company Address
SUITE 500, 5050 Satellite Drive, Mississauga, Ontario, Canada, L4W 0G1
Active Ingredients
PALOVAROTENE
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
87f1a32ae6a3b909
Type
Standard
Back to Health Canada Approvals